A detailed history of Handelsinvest Investeringsforvaltning transactions in Repligen Corp stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 1,434 shares of RGEN stock, worth $200,659. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,434
Previous 2,179 34.19%
Holding current value
$200,659
Previous $392,000 32.65%
% of portfolio
0.13%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$170.78 - $208.42 $127,231 - $155,272
-745 Reduced 34.19%
1,434 $264,000
Q4 2023

Jan 11, 2024

SELL
$114.17 - $185.35 $2.03 Million - $3.3 Million
-17,821 Reduced 89.11%
2,179 $392,000
Q3 2023

Oct 26, 2023

BUY
$138.78 - $176.51 $2.78 Million - $3.53 Million
20,000 New
20,000 $3.18 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.76B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.